Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021264
Company: MDD US

Products on NDA 21264

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
APOKYN	APOMORPHINE HYDROCHLORIDE	20MG/2ML (10MG/ML)	INJECTABLE;SUBCUTANEOUS	Discontinued	None	No	No
APOKYN	APOMORPHINE HYDROCHLORIDE	30MG/3ML (10MG/ML)	INJECTABLE;SUBCUTANEOUS	Prescription	AP	Yes	Yes

Labels for NDA 021264

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/03/2025	SUPPL-25	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021264s025lbl.pdf
06/22/2022	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021264s021lbl.pdf
06/22/2022	SUPPL-21	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021264s021lbl.pdf
05/05/2022	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021264s022lbl.pdf
05/05/2022	SUPPL-22	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021264s022lbl.pdf
05/01/2020	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021264s018lbl.pdf
12/03/2019	SUPPL-17	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021264Orig1s017lbl.pdf
12/03/2019	SUPPL-17	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021264Orig1s017lbl.pdf
12/03/2019	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021264Orig1s017lbl.pdf
05/20/2019	SUPPL-16	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021264s016lbl.pdf
05/20/2019	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021264s016lbl.pdf
03/16/2017	SUPPL-14	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021264s014lbl.pdf
07/25/2014	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021264s010lbl.pdf
09/02/2010	SUPPL-9	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021264s009lbl.pdf
04/20/2004	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21264_apokyn_lbl.pdf